[1]
Donica, H. et al. 2012. Comparison of diagnostics power of chromogranin Aelisa test in general population of patients with neuroendocrine tumors and with metastases. Current Issues in Pharmacy and Medical Sciences. 24, 4 (Oct. 2012), 167–175. DOI:https://doi.org/10.12923/.